PRLog - March 20, 2012 - TORONTO -- According to news-medical.net, “Researchers from Boston University School of Medicine (BUSM) have found that a health care provider’s attitude toward male human papillomavirus (HPV) vaccination may influence the implementation of new guidelines.”
These researchers believe providing healthcare providers with education on the benefits of HPV vaccination for male patients, may be important for reaching HPV vaccination goals.
The American Journal of Men’s Health reported the researcher’s findings.
The Center for the Biology of Chronic Disease (CBCD), in contrast, points to other findings which show that there is no evidence that Gardasil is effective in preventing either genital warts or cancer in young men.
A Discover Magazine article points to the fact that “Merck’s study of HPV vaccine efficacy in males published in the New England Journal of Medicine states that Gardasil is 89% effective against genital warts and 75% effective against anal cancer.
Given the fact that there are approximately 300 annual deaths from of anal/rectal cancer among men in the United States, one wonders how Merck was able to prove such a huge reduction in such a rare problem.
As with the female group, external lesions substituted for actual cancer with no proof that lesions of that type actually lead to cancer at all. Yet, Merck’s statistics regarding their cancer substitute penile/perianal/
And for HPV strain 18-related genital lesions, there were actually more lesions in the vaccinated group than the placebo group. So as in the previous study, Merck’s impressive numbers for the efficacy of Gardasil in men can only be attained by excluding one-quarter of the study participants. When everyone is included and all outcomes are assessed, the efficacy drops to zero!” 
The CBCD believes one must ask whether HPV vaccination goals should be met at all when it appears there is little more than hope and guesswork behind these recommendations.
As with other conditions, the CBCD promotes education as key in preventing any form of HPV infection.
The HPV virus a type of virus that eventually goes into periods of latency (dormancy), where it behaves as if it is hibernating, or sleeping.
The person is not sick when the virus is dormant, or latent, as scientists call it. In fact, the Food and Drug Administration (FDA) says “Some viruses … can enter a state known as latency in which the virus is not being replicated. In the latent state, the virus does not cause disease.”
It is always possible that dormant viruses will reactivate, however. This is why the CBCD believes it is so important that the public should be boosting their immune systems against the dormant HPV virus.
A dormant virus is a genetic parasite that steals limited genetic resources needed by the body’s cells. As opposed to the FDA’s view, Dr. Hanan Polansky brought to light the biological mechanism through which this foreign DNA causes disease.
This discovery is named Microcompetition with Foreign DNA. Dr. Polansky’s “Purple Book” discusses these concepts and is available as a free download at: http://www.cbcd.net.
What can people do against the latent (dormant) HPV virus?
There is no drug that can kill the dormant HPV virus in infected individuals. However, there is an all natural, evidence based, scientific remedy that helps the immune system fight off dormant (latent) viruses. It is called Gene-Eden-VIR.
Gene-Eden-VIR does not offer a cure, and is not a drug. However, the CBCD believes that Gene-Eden-VIR is an antiviral remedy that effectively boosts the immune system against dormant viruses. It is a product everyone should consider.
Most people may wonder whether Gene-Eden-VIR is an affordable, safe and effective HPV remedy.
Gene-Eden-VIR is sold online exclusively through the gene-eden.com website. A bottle costs $34.99 and includes a month’s supply of Gene-Eden-VIR. Thus, it is very affordable.
In regard to safety, in over three years of being on the market, there have been no reports of side effects according to polyDNA. Moreover, each bottle is GMP certified, which means that the product is keeping good manufacturing practices as outlined by the Food and Drug Administration (FDA).
In terms of effectiveness against the dormant HPV virus, each Gene-Eden-VIR capsule contains a patented formula of five natural ingredients, each at a uniquely selected dose.
These ingredients were chosen after extensive research through a scientific method developed by Dr. Hanan Polansky. The method is based on electronic and manual analysis of thousands of scientific and medical papers published on the topic of research.
Individuals can find real scientific references explaining exactly what works, why, and how by going to Pubmed.gov and looking up peer reviewed, scientific papers published on Gene-Eden-VIR’
(Many of these studies are also mentioned on the Gene-Eden website.)
“Gene-Eden combines several proven substances that work harmoniously to help boost the body’s own immune system or have other antiviral properties. The scientific data with regard to the immune enhancing and antiviral properties published in reputable sources on each individual compound in the Gene-Eden formula is impressive. Use of this product clearly has scientific merit based on published material.” – Dr. Norman Cohen, MD
The CBCD believes that the Gene-Eden website located at http://www.gene-
For more information on Gene-Eden-VIR, visit the Gene-Eden-VIR website at http://www.gene-
For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with one of our researchers, please visit http://www.cbcd.net or call 585-250-9999.
 Lenzer J, Should Boys be Given the HPV Vaccine? The Science is Weaker than the Marketing, Discover Magazine, November 14, 2011.
# # #
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net)
The CBCD published the “Purple Book” by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of dormant (latent) viruses and the onset of major diseases, such as cancer, obesity, heart disease, arthritis, diabetes, and others. Dr. Polansky’s book is available as a free download from the CBCD website.